In-Vitro Diagnostics Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2025 | Emphasis on Techniques (Immunoassay, Clinical Chemistry, SMBG, Molecular Diagnostics, Hematology, Microbiology, Point-of-Care, Hemostasis)

Global In-Vitro Diagnostics Market was valued at US$ 68.92 billion in 2018 and is anticipated to reach US$ 98.18 billion by 2025 displaying a reasonable CAGR of 5.24% over the forecast period (2019-2025). Global In-Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to detect infection, diagnose a medical condition, prevent disease and monitor drug therapies. The market of the In-Vitro Diagnostics market is anticipated to grow enormously owing to factors such as rising geriatric population, increasing the prevalence of chronic diseases, increasing adoption of Point-of-care diagnosis, and technology advancement in the In-Vitro Diagnostics technology. Rising demand for Point-of-Care (POC) devices is expected to fuel the market growth in the near future. In addition, the introduction of advanced technologies, such as biochips and nano-biotechnology, and miniaturization of microfluidics are expected to increase the demand for PoC products. These advancements have enabled easy access to PoC diagnostic tests and are likely to facilitate quick and effective test results, thereby boosting the overall market growth. The changing reimbursement models and regulations, investing in unifying technology would mark as a trend in this industry. However, stringent government regulations for the manufacturing of IVD products will act as the major challenges in the growth of this market.

“Reagents dominated the product segment of the global In-Vitro Diagnostics market with 69.0% share in 2018”

Based on Product type the global in-vitro diagnostics market is segmented into reagents and Instruments Services. The market of the Reagents segment is expected to grow tremendously and is projected to dominate the market in 2025 due to its high demand in over-the-counter diagnostic tests, paired with rising demand for these for tests at non-medical facilities such as a home.

Request for Sample of the Report - https://univdatos.com/request_form/form/237 

“Immunoassay technique of In-Vitro Diagnostic dominated the market in 2018”

Based on techniques the global In-Vitro Diagnostics market is segmented into Immunoassay, Clinical Chemistry, SMBG, Molecular Diagnostics, Hematology, Microbiology, Point-of-Care, and Hemostasis. The Immunoassay technique occupied the largest share of 24.7% in 2018 and is expected to maintain its dominance throughout the forecast period 2019-2025. However, Molecular Diagnostics and Point-of-Care testing techniques are expected to witness the highest CAGR growth during the analyzed period, owing to increasing demand for such tests at home.

“In-Vitro Diagnostic technology was majorly applied for the treatment or diagnosis of Infectious Disease”

Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases are the major applications of In-Vitro Diagnostics technology. In 2018, IVD was majorly used for the treatment and diagnosis of Infectious Diseases. The segment is expected to witness CAGR 4.89% during the forecast period 2019-2025 to generate revenue of US$ 33.73 billion by 2025. However, Oncology treatment using IVD is expected to grow at the highest rate during the analyzed period.

For Regional/country-wise analysis of the overall adoption of In-Vitro Diagnostics technology in different healthcare facilities browse through - https://univdatos.com/report/in-vitro-diagnostic-market-current-scenario-and-forecast-2019-2025

“Hospitals were the major end-users of In-Vitro Diagnostic technology in 2018”

Based on end-users, the global In-Vitro Diagnostics market is bifurcated into hospitals, clinics & labs, home care, and other healthcare facilities. In 2018, the hospital segment occupied 47.6% share. However, the use of technology for home disease treatment is expected to witness the highest CAGR growth dusting the forecast period 2019-2025. The growing elderly population and associated diseases would help the segment to witness such growth.

“Reusable IVD Devices are expected to dominate the usability segment of the global in-vitro diagnostics market during the analyzed period.”

In-Vitro Diagnostics market segmented based on usability include reusable and disposable IVD devices. The Reusable IVD Devices occupied the largest share and is expected to maintain its dominance throughout the forecast period 2019-2025.

“North America represents one of the largest markets of the In-Vitro Diagnostics market globally in 2018”

For a deep-dive analysis of the industry and its adoption rate, detailed regional/country-level analysis was conducted for regions including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, Italy, UK and Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of the World (Brazil and Others). In 2018, North America dominated the market, however, the growing elderly population in Europe and Asia-Pacific would help the region to use more of in-vitro diagnostic technology for disease detection and treatment.

Feel free to contact us for any queries - https://univdatos.com/request_form/form/237 

Competitive Landscape-Top 10 Market Players

Abbott Laboratories, Becton Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, Johnson & Johnson, Roche, Siemens Healthineers AG, Sysmex Corporation and Thermo Fisher Scientific are some of the prominent players operating in the Global In-Vitro Diagnostics market industry. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products in the In-Vitro Diagnostic sector.

The Global In-Vitro Diagnostics Market can be customized to the country level or any other market segment. Besides this, UnivDatos Market Insights (UMI) understands that you may have your own business need, hence we also provide fully customized solutions to clients.

Molecular Diagnostics Market (2019-2025) - https://www.prlog.org/12802549-molecular-diagnostics-market-industry-analysis-size-share-growth-trends-forecast-2019-2025.html 

Point-of-Care Testing Market (2019-2025) - http://prsync.com/univdatos-market-insights-/point-of-care-testing-market---industry-analysis-size-share-growth-trends-and-forecast---3186665/ 

UnivDatos Market Insights (UMI)
E-14B, Sector-8, Noida
India
Tel: 0120-4326511
Email: sales@univdatos.com
Web: https://univdatos.com

UnivDatos Market Insights (UMI) is a rapidly emerging market research firm that offers the most relevant and effective research solutions. With our unique approach to gathering valuable data and using actionable insights, we help our clients develop winning market strategies, so they can explore market-entry and growth opportunities to drive smart decisions.

This release was published on openPR.